Physician profile
Stephen L Steele
NPI 1376837344
$9,323.42
in general payments reported to CMS, 2019-2025
35 companies · $1,912 in 2025
The $1,912 reported for 2025 was more than what 78% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $547 · 2021: $1,431 · 2022: $1,224 · 2023: $1,426 · 2024: $2,111 · 2025: $1,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,449.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,440.73 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $975.26 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Gilead Sciences, INC. | $825.06 | 2019-2025 | |
| Janssen Biotech, INC. | $780.62 | 2020-2025 | Stelara, Tremfya, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $541.91 | 2021-2025 | Xifaxan, Relistor, Trulance |
| Pfizer INC. | $350.19 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $350.08 | 2024-2025 | Voquezna |
| Ardelyx, INC. | $323.92 | 2022-2025 | Ibsrela |
| Genzyme Corporation | $285.34 | 2023-2025 | |
| Evoke Pharma, INC. | $213.56 | 2022-2025 | Gimoti |
| Intercept Pharmaceuticals, INC. | $164.60 | 2020-2025 | Ocaliva |
| Lilly USA, LLC | $146.43 | 2024-2025 | Omvoh |
| Merck Sharp & Dohme LLC | $117.93 | 2021-2024 | Dificid |
| Braintree Laboratories, INC. | $100.02 | 2021-2023 | Sutab |
| Celgene Corporation | $64.22 | 2023-2024 | Zeposia |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $61.31 | 2019-2020 | |
| Redhill Biopharma INC. | $55.17 | 2021 | |
| Madrigal Pharmaceuticals | $52.75 | 2025 | Rezdiffra |
| Amgen INC. | $47.46 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $40.86 | 2021-2023 | |
| Ucb, INC. | $40.27 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $38.10 | 2023 | Dupixent |
| Medtronic, INC. | $37.77 | 2021-2023 | Endoflip |
| Ironwood Pharmaceuticals, INC | $34.91 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $34.65 | 2025 | Iqirvo |
| Boston Scientific Corporation | $34.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.62 | 2024 | Imfinzi |
| Ferring Pharmaceuticals INC. | $24.05 | 2024 | Rebyota |
| Novo Nordisk INC | $20.61 | 2023 | Wegovy |
| Mauna Kea Technologies, INC. | $17.35 | 2024 | |
| Daiichi Sankyo INC. | $17.10 | 2020 | |
| Enterra Medical, INC. | $16.46 | 2023 | |
| Celltrion USA INC. | $15.14 | 2025 | Vegzelma |
| Alnylam Pharmaceuticals INC. | $14.85 | 2024 | Givlaari |
| Organon LLC | $11.56 | 2023 | Renflexis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.